News & Information

Transplant Living News provides the latest news about pre- and post-transplant therapies, surgical technologies and research in the field of transplantation. Please refer to the news from the past 30 days listed below.


Keyword Search:
Submit Search Help

Articles Published Within Last 30 Days
03/01/2010 U.S. FDA panel backs transplant drug belatacept
 
WASHINGTON, March 1 (Reuters) - Bristol-Myers Squibb Co's experimental kidney transplant drug belatacept should be approved to give doctors and patients more treatment choices, but long-term data and a stringent patient registry are needed, U.S. medical advisers said on Monday.
02/24/2010 When patients with failed kidney grafts stop immunosuppression, their cancer risks fall
 
NEW YORK (Reuters Health) - The risk for infection-related cancers in kidney transplant recipients falls dramatically when immunosuppression is stopped after graft failure, according to a study from Australia and New Zealand.